secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-06-09T12:30:22+00:00
Accession:  0001493152-26-027861
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical secures first Midwest account, Michigan health system adopts LIBERTY System
--------------------------------------------------------------------------------

- First Midwest-based account: a large Michigan healthcare system adopts LIBERTY Endovascular Robotic System.
- Follows recent expansion into North Carolina, reflecting growing U.S. presence after full market release.
- LIBERTY also received regulatory approval from Israel Ministry of Health to market and sell in Israel.
- U.S. market for peripheral endovascular procedures approximately 2.5 million annually.
- CEO Harel Gadot cites increasing interest from physicians and hospital leaders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226027861/0001493152-26-027861-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226027861/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027861

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer